Hemin

Basic Information

Item Value
DrugBank ID DB03404
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 thrombocytopenic purpura KG + DL
2 hemophilia KG + DL
3 C1 inhibitor deficiency KG + DL
4 acquired coagulation factor deficiency KG + DL
5 serpinopathy with toxic serpin polymerization KG + DL
6 hereditary angioedema with C1Inh deficiency KG + DL
7 inherited thrombophilia KG + DL
8 symptomatic form of hemophilia in female carriers KG + DL
9 hereditary von Willebrand disease KG + DL
10 congenital factor XI deficiency KG + DL
11 inherited prekallikrein deficiency KG + DL
12 pancreatitis KG + DL
13 flood factor deficiency KG + DL
14 thrombotic thrombocytopenic purpura KG + DL
15 von Willebrand disease KG + DL
16 Von Willebrand disease, X-linked form KG + DL
17 Scott syndrome KG + DL
18 immune-mediated necrotizing myopathy KG + DL
19 antisynthetase syndrome KG + DL
20 focal myositis KG + DL
21 familial thrombomodulin anomalies KG + DL
22 hereditary thrombocytosis with transverse limb defect KG + DL
23 methylcobalamin deficiency type cblG KG + DL
24 inflammatory myopathy with abundant macrophages KG + DL
25 idiopathic eosinophilic myositis KG + DL
26 juvenile nasopharyngeal angiofibroma (disease) KG + DL
27 familial nasal acilia KG + DL
28 indomethacin embryofetopathy KG + DL
29 silent sinus syndrome KG + DL
30 branchial cleft anomaly KG + DL
31 craniorhiny KG + DL
32 velo-facial-skeletal syndrome KG + DL
33 maternal hyperthermia induced birth defects KG + DL
34 fetal trimethadione syndrome KG + DL
35 Pick disease KG + DL
36 fetal minoxidil syndrome KG + DL
37 familial apolipoprotein C-II deficiency KG + DL
38 phenobarbital embryopathy KG + DL
39 cleft lip/palate-intestinal malrotation-cardiopathy syndrome KG + DL
40 cocaine embryofetopathy KG + DL
41 Bencze syndrome KG + DL
42 mandibulofacial dysostosis-macroblepharon-macrostomia syndrome KG + DL
43 diabetic embryopathy KG + DL
44 hemophilia A with vascular abnormality KG + DL
45 primary hyperoxaluria KG + DL
46 genetic otorhinolaryngological malformation KG + DL
47 aminopterin/methotrexate embryofetopathy KG + DL
48 bleeding diathesis due to a collagen receptor defect KG + DL
49 osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome KG + DL
50 toluene embryopathy KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.